Connect Biopharma (CNTB) Institutional Ownership $1.11 +0.12 (+12.12%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Connect Biopharma (NASDAQ:CNTB)CurrentInstitutional OwnershipPercentage58.72%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$2.54MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$41.95K Get CNTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Connect Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNTB Institutional Buying and Selling by Quarter Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Connect Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/5/2024 BML Capital Management LLC2,093,232$3.01M1.8%+2.4%3.789% 8/9/2024 Renaissance Technologies LLC212,300$323K0.0%-11.5%0.385% 7/17/2024 Keudell Morrison Wealth Management32,200$49K0.0%+63.5%0.058% 5/7/2024 Keudell Morrison Wealth Management19,700$34K0.0%+75.9%0.036% 1/30/2024 BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743% 8/15/2023 Kynam Capital Management LP535,005$603K0.1%-27.7%0.972% Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022 Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049% 8/16/2022 DAFNA Capital Management LLC250,000$218K0.1%N/A0.454% 5/13/2022 Kynam Capital Management LP227,759$688K0.2%N/A0.414% 2/22/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022 Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174% 2/14/2022 Altium Capital Management LP175,000$901K0.2%N/A0.304% 2/14/2022 Deep Track Capital LP647,057$3.33M0.2%N/A1.125% 2/11/2022 Ensign Peak Advisors Inc25,412$131K0.0%N/A0.044% 11/16/2021 Janus Henderson Group PLC403,459$9.57M0.0%+3.1%0.702% 11/16/2021 Wellington Management Group LLP1,145,177$27.37M0.0%-25.3%1.991% 11/12/2021Vident Investment Advisory LLC10,851$263K0.0%N/A0.019% 11/9/2021BlackRock Inc.2,450,065$59.37M0.0%-0.3%4.261% 11/5/2021 Daiwa Securities Group Inc.6,069$147K0.0%N/A0.011% 8/17/2021 Millennium Management LLC42,856$837K0.0%+286.1%0.075% 8/17/2021 Old Well Partners LLC122,431$2.39M1.1%N/A0.213% 8/16/2021 RA Capital Management L.P.6,991,003$136.53M2.2%+133.7%12.157% 8/16/2021 Federated Hermes Inc.12,000$234K0.0%-70.0%0.021% 8/13/2021 FMR LLC3,925,836$76.67M0.0%+23.3%6.827% 8/11/2021BlackRock Inc.2,458,132$48.01M0.0%+0.3%4.275% 8/10/2021 Citigroup Inc.1,413$28K0.0%N/A0.002% 5/19/2021 Logos Global Management LP150,000$2.78M0.3%N/A0.261% 5/19/2021 Octagon Capital Advisors LP373,492$6.91M2.6%N/A0.650% 5/18/2021 Millennium Management LLC11,099$205K0.0%N/A0.019% 5/18/2021 Zimmer Partners LP10,000$185K0.0%N/A0.017% 5/18/2021 RA Capital Management L.P.2,991,208$55.34M0.8%N/A5.202% 5/18/2021 State of Wisconsin Investment Board100,272$1.86M0.0%N/A0.174% 5/18/2021 Alyeska Investment Group L.P.50,000$925K0.0%N/A0.087% 5/18/2021 Boxer Capital LLC2,081,323$38.50M1.3%N/A3.619% 5/18/2021 Cormorant Asset Management LP1,000,000$18.50M0.4%N/A1.739% 5/18/2021 Citadel Advisors LLC245,191$4.54M0.0%N/A0.426% 5/17/2021 Point72 Hong Kong Ltd10,426$193K0.0%N/A0.018% 5/17/2021 Rock Springs Capital Management LP119,114$2.20M0.0%N/A0.207% 5/17/2021 DAFNA Capital Management LLC8,000$148K0.0%N/A0.014% Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov5/17/2021 Janus Henderson Group PLC475,000$8.70M0.0%N/A0.826% 5/17/2021Pinz Capital Management LP43,100$797K0.2%N/A0.075% 5/17/2021 Sphera Funds Management LTD.50,000$925K0.1%N/A0.087% 5/14/2021 RTW Investments LP450,000$8.33M0.1%N/A0.783% 5/14/2021 Monashee Investment Management LLC110,000$2.04M0.3%N/A0.191% 5/13/2021 Federated Hermes Inc.40,000$740K0.0%N/A0.070% (Data available from 1/1/2016 forward) CNTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNTB shares? During the previous two years, the following institutional investors and hedge funds held shares of Connect Biopharma shares: BML Capital Management LLC ($3.01M), Kynam Capital Management LP ($603K), and Renaissance Technologies LLC ($323K), Keudell Morrison Wealth Management ($49K).Learn more on CNTB's institutional investors. What percentage of Connect Biopharma stock is owned by institutional investors? 58.72% of Connect Biopharma stock is owned by institutional investors. Learn more on CNTB's institutional investor holdings. Which institutional investors have been buying Connect Biopharma stock? The following institutional investors have purchased Connect Biopharma stock in the last 24 months: BML Capital Management LLC ($2.11M), and Keudell Morrison Wealth Management ($21K). How much institutional buying is happening at Connect Biopharma? Institutional investors have bought a total of 2,132,422 shares in the last 24 months. This purchase volume represents approximately $2.54M in transactions. Which Connect Biopharma major shareholders have been selling company stock? The following institutional investors have sold Connect Biopharma stock in the last 24 months: Kynam Capital Management LP ($204.64K), and Renaissance Technologies LLC ($27.60K). How much institutional selling is happening at Connect Biopharma? Institutional investors have sold a total of 232,244 shares in the last 24 months. This volume of shares sold represents approximately $273.20K in transactions. Related Companies RAPT Institutional Ownership OPT Institutional Ownership ATAI Institutional Ownership NKTX Institutional Ownership LFCR Institutional Ownership AMRN Institutional Ownership INBX Institutional Ownership ENTA Institutional Ownership SOPH Institutional Ownership XBIT Institutional Ownership This page (NASDAQ:CNTB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNTB Stock Alerts